Soleno Therapeutics, Inc.
Inspired by patients and families around the world
Redwood City, United States · Founded 2015
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- soleno.life
About
Soleno Therapeutics is a publicly traded biopharmaceutical company (NASDAQ: SLNO) focused on developing and commercializing novel therapeutics for rare genetic disorders. Their first commercial product, VYKAT XR (diazoxide choline extended-release tablets), received FDA approval in March 2025 as a once-daily oral treatment for hyperphagia in patients with Prader-Willi syndrome aged 4 and older. The company is headquartered in Redwood City, California.
Summary
Soleno Therapeutics, Inc. is a Biotech company based in Redwood City, United States, founded in 2015.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/soleno-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/soleno-therapeutics-inc" alt="Soleno Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>